Go to main content
logo unither pharmaceuticals site internet
  • 简体中文 | ZH-HANS
  • Français | FR
  • Português | PT-BR
  • Services
    • Manufacturing
      • Technology Transfer & Scale-Up
      • Commercial batches manufacturing
      • Small-batch manufacturing – rare diseases
      • Small-batch manufacturing – veterinary
    • Development
      • Formulation Development
      • Analytical Development
      • Clinical Batch & Placebo Manufacturing
      • Stability Studies
      • Ophthalmic Development
      • Co-Development Program
      • Regulatory Support
    • Out-licensing
      • Medical devices
      • Drugs
      • Product List
  • Solutions
    • By technology
      • Sterile liquids
      • Blow-Fill-Seal (BFS)
      • Multi-Dose
      • Non-sterile liquids
      • Stick-Pack
      • Spray
      • Bottle
      • Other
      • Solids & Semi-Solids
    • By therapeutic area
      • Ophthalmology
      • ENT
      • Injectable
      • Respiratory
      • Rare Diseases
      • Other Therapeutic Areas

    • Breakthrough Solutions
      • Euroject® – BFS Injectable
      • Carragelose – Viral Infection
      • Sol-Gel™ – Ophthalmology
      • Uniflash® – Oro-mucosal
    • Turnkey products
      • Medical devices
      • Drugs
      • Product List
  • The Group
    • About Us
      • About Us
      • Vision and Innovation
      • Executive Committee
      • History
    • Global presence
      • Overview
      • In France
      • In Brazil
      • In the United States
      • In China
    • Commitment
      • Cap 2030: our CSR strategy
      • Responsible Purchasing
    • News
      • News
      • Agenda
      • Press Area
  • Careers
    • Careers
      • Working at Unither
      • Our job opportunities
  • Inspire Hub
  • Contact
Site search
Press Enter to start the search
News
News

News

 Category filters

 Filter by categories:

 Select categories

 List of articles

News

Win a Compatibility Study For Injectable Products 

Corporate

Construction of a New Industrial Facility in Gannat

News

Official launch of the CURECALL solution to ophthalmologists in France!

News

UNITHER invests 68 million euros in the innovative project: Euroject®

Uncategorized

Laboratoire Kôl Olisens® eye drops, manufactured by Unither Pharmaceuticals

Article News

Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division

News Uncategorized

Rare Disease Day

News

Using Differentiated Drug-Delivery Technologies to Deliver Competitive Advantages

Uncategorized

Why China is becoming strategic for Ophthalmology and CDMOs

Liquid Delivery Systems for ENT Applications

Presse

Partnership with SeaBeLife to develop and produce ophthalmic drug candidate

News

Advancing ophthalmology: Unither invests in its French R&D site.

1 2 3 Next >

Services

  • Manufacturing
  • Development
  • Out-licensing

Solutions

  • By technology
  • By therapeutic area
  • Breakthrough Solutions
  • Product notices

The group

  • About Us
  • Vision and Innovation
  • Executive Committee
  • History

Inspire Hub

Follow Us

  • X (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • YouTube (opens in a new tab)

Newsletter Signup

Newsletter
  • Legal links menu
  • Code of Conduct
  • Procurement Policy
  • Legal Notice
  • Privacy Policy